Anna Bortnick
Interventional Cardiology · Bronx, NYNPI 1346391869
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,416 of the $3,953 with a category attached, or 86.4%. It is spread thinly across 15 manufacturers, the largest accounting for just 21.0% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for interventional cardiology clinicians in NY, where the typical reported total is $8,047.
Across 40 payments — averaging $98.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$831
- Medtronic$539
- Getinge USA Sales, LLC$538
- Cardiovascular Systems Inc.$392
- Abiomed$370
- Abbott$307
- plus $978 from 9 others
Across 117 payments — averaging $1614.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$145K
- Abbott$16K
- Amgen$12K
- Janssen Research & Development, LLC$12K
- AstraZeneca$5K
What the payments were for
- Travel & lodging$53814%
- Food & beverage$3,41686%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 12 | $831 |
| Medtronic | 5 | $539 |
| Getinge USA Sales, LLC | 1 | $538 |
| Cardiovascular Systems Inc. | 3 | $392 |
| Abiomed | 3 | $370 |
| Abbott | 3 | $307 |
| Inari Medical, Inc. | 2 | $199 |
| Philips North America LLC | 2 | $167 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $143 |
| Esperion Therapeutics, Inc. | 1 | $137 |
| Livanova USA, Inc. | 1 | $133 |
| Spectrawave, Inc | 1 | $104 |
| Amgen | 2 | $43 |
| Siemens Medical Solutions USA, Inc. | 1 | $28 |
| Stryker | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vasoview Hemopro 2$538
- Diamondback Coronary$304
- Resolute$250
- OPTIS$204
- GENERAL ATHERECTOMY$153
- Turbo Elite$142
- GENERAL - STRUCTURAL HEART$140
- GENERAL - THERAPIES$140
- NEXLETOL$137
- NEXLIZET$137
- Impella$136
- FLOWTRIEVER CATHETER, S$135
- CT THROMBECTOMY SYSTEM KIT$135
- LifeSPARC$133
- GENERAL ULTRASOUND$125
- FFRangio$119
- LifeVest$106
- HyperVue Imaging System$104
- Starlight Imaging Catheter$104
How this compares
$3,953 in reported general payments places this provider in the 30th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 26 | $36,793 |
| EntrestoSacubitril/Valsartan | 34 | $32,112 |
| Repatha SureclickEvolocumab | 28 | $22,350 |
| OzempicSemaglutide | 15 | $15,850 |
| EliquisApixaban | 18 | $15,266 |
| XareltoRivaroxaban | 12 | $15,046 |
| BrilintaTicagrelor | 13 | $11,314 |
| Metoprolol Succinate | 101 | $1,814 |
| Ezetimibe | 23 | $945 |
| Nifedipine ErNifedipine | 35 | $814 |
| Atorvastatin Calcium | 77 | $798 |
| Rosuvastatin Calcium | 48 | $553 |
| Losartan Potassium | 35 | $342 |
| Nitroglycerin | 13 | $334 |
| ClopidogrelClopidogrel Bisulfate | 32 | $267 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Bronx
- Mohamed Azeem LatibBronx$816K
- Sahil ParikhNew York$1.6M
- Deepak BhattNew York$1.6M
- Martin LeonNew York$1.5M
- Evan ShlofmitzRoslyn$951K
- Yili HuangElmhurst$699K
- Ali HaiderAstoria$492K
- Sripal BangaloreNew York$482K
- Ajay KirtaneNew York$462K
- David CohenRoslyn$392K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.